NS
Article DetailSEC EDGAR Filings
首页文档检索台
SEC EDGAR Filings

4 - Prelude Therapeutics Inc

Filed: 2026-04-23 AccNo: 0000947871-26-000461 Size: 15 KB
查看原文来源主页查看事件簇按来源查看
发布时间04/23 22:48 UTC
首次发现04/23 22:54 UTC
热度106.2
重要度74
情绪0.00

站内整理正文

优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 399 字符

Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0000947871-26-000461

Filing Date: 2026-04-23

Accepted: 2026-04-23 18:48:25

Documents: 1

Period of Report: 2026-04-21

ORBIMED ADVISORS LLC ( Reporting ) CIK : 0001055951 (see all company filings) State of Incorp.: DE Type: 4 | Act: 34 | File No.: 001-39527 | Film No.: 26890058

1 | ownership.xml | 4 | 12463

同簇相关文章

从当前文章回到同一事件簇里的其他来源或补充材料。
2 篇